CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roland, E. J.
Right arrow Articles by Roupie, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roland, E. J.
Right arrow Articles by Roupie, E.

Canadian Journal of Anesthesia, Vol 41, 694-698, Copyright © 1994 by Canadian Anesthesiologists' Society

ARTICLES

Pharmacodynamic behaviour of vecuronium in primary hyperparathyroidism

EJ Roland, JM Wierda, BG Eurin and E Roupie
Department of Anesthesiology and Surgical Intensive Care, Hopital Universitaire Saint Louis, Paris, France.

This study evaluated the potency and time course of action of vecuronium in patients with primary hyperparathyroidism (HPT) and marked hypercalcaemia during nitrous oxide-opioid anaesthesia. Twenty ASA physical status I and II patients were studied by measuring the force of contraction of the adductor pollicis in response to stimulation of the ulnar nerve: ten control patients and ten patients with HPT and ionized calcium concentration over 2.80 mEq.L-1. After induction of anaesthesia with thiopentone and maintenance with N2O/O2 and fentanyl, vecuronium was administered to determine cumulative dose-response curves. When maximum block had been obtained, twitch height was maintained at 10% of baseline value over 20 min by adjusting the infusion rate of a syringe-pump containing vecuronium and vecuronium plasma concentration (EC90ss) was determined. During spontaneous recovery, after termination of infusion, the recovery index, the time from 25 to 75% recovery, was measured. The dose to produce 90% block was greater in the HPT than in control group: 69 (24) vs 54 (18) micrograms.kg-1 (P < 0.02). The calculated ED50 was also greater in HPT: 42 (4) vs 31 (5) micrograms.kg-1 in controls (P < 0.001). (Values are given as mean and coefficient of variation). The slope of the dose-response curve, the dose necessary to maintain 90% block, and the EC90ss did not differ. The RI25-75 was slower in the HPT group although the difference did not reach statistical significance. It is concluded that hyperparathyroidism with hypercalcaemia increases vecuronium requirement; only during the onset of neuromuscular blockade.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
M. J. Bolland, A. B. Grey, G. D. Gamble, and I. R. Reid
Association between Primary Hyperparathyroidism and Increased Body Weight: A Meta-Analysis
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1525 - 1530.
[Abstract] [Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
M. A. Munir, M. Jaffar, M. Arshad, M. S. Akhter, and J. Zhang
Reduced duration of muscle relaxation with rocuronium in a normocalcemic hyperparathyroid patient: [Relachement musculaire de duree reduite avec le rocuronium chez un patient normocalcemique presentant une hyperparathyroidie]
Can J Anesth, June 1, 2003; 50(6): 558 - 561.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the Canadian Anesthesiologists' Society.